Danish company making progress in Merck-deal

Nordic Bioscience is currently carrying out extensive phase II trials that the Danish company has to conduct for Merck Serono in accordance with a partnership deal.

Photo: Merck Serono/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles